Biosimilar Monoclonal Antibody Market Report

China Biosimilar Monoclonal Antibody Industry Market Research Report 2023-2029

  • POSTDATE：Aug 30, 2023
  • PAGES：146
  • REPORT CODE：GMM1766040
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Biosimilar Monoclonal Antibody industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Intas Pharmaceuticals Limited

    • Genor BioPharma Co Ltd

    • Dr Reddys Laboratories Ltd

    • Coherus BioSciences Inc

    • BIOCAD BioXpress

    • Biocon Limited

    • Therapeutics SA

    • Boehringer Ingelheim GmbH

    • Celltrion Inc

    By Type:

    • Biopharmaceuticals

    • Others

    • Synthetic Chemicals

    By Application:

    • Chronic & Autoimmune Diseases

    • Oncology

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Biosimilar Monoclonal Antibody Market Overview 2018-2029

    • 1.1 China Biosimilar Monoclonal Antibody Industry Development Overview

    • 1.2 China Biosimilar Monoclonal Antibody Industry Development History

    • 1.3 China Biosimilar Monoclonal Antibody Industry Market Size (2018-2029)

    • 1.4 China Biosimilar Monoclonal Antibody Market Analysis by Type from Production Side

      • 1.4.1 China Biosimilar Monoclonal Antibody Production Volume, Production Value and Growth Rate of Biopharmaceuticals (2018-2029)

      • 1.4.2 China Biosimilar Monoclonal Antibody Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Biosimilar Monoclonal Antibody Production Volume, Production Value and Growth Rate of Synthetic Chemicals (2018-2029)

    • 1.5 China Biosimilar Monoclonal Antibody Market Analysis by Application from Consumption End

      • 1.5.1 China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate of Chronic & Autoimmune Diseases (2018-2029)

      • 1.5.2 China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.3 China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Biosimilar Monoclonal Antibody Market Analysis by Region

      • 1.6.1 North China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    Chapter 2 China Biosimilar Monoclonal Antibody Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Biosimilar Monoclonal Antibody Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Biosimilar Monoclonal Antibody Market Status and Competition Analysis in 2023

      • 2.2.3 China Biosimilar Monoclonal Antibody Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Biosimilar Monoclonal Antibody Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Biosimilar Monoclonal Antibody Industry Development

    Chapter 3 Biosimilar Monoclonal AntibodyIndustry Chain Analysis

    • 3.1 Biosimilar Monoclonal Antibody Industry Chain

    • 3.2 Biosimilar Monoclonal Antibody Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Biosimilar Monoclonal Antibody Market

    • 3.3 Biosimilar Monoclonal Antibody Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Biosimilar Monoclonal Antibody Market

    Chapter 4 China Biosimilar Monoclonal Antibody Market, by Type

    • 4.1 China Biosimilar Monoclonal Antibody Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Biosimilar Monoclonal Antibody Total Production Volume and Growth Rate from Production Side

    • 4.5 China Biosimilar Monoclonal Antibody Production Volume and Growth Rate, by Type

      • 4.5.1 China Biosimilar Monoclonal Antibody Production Volume and Growth Rate of Biopharmaceuticals

      • 4.5.2 China Biosimilar Monoclonal Antibody Production Volume and Growth Rate of Others

      • 4.5.3 China Biosimilar Monoclonal Antibody Production Volume and Growth Rate of Synthetic Chemicals

    Chapter 5 China Biosimilar Monoclonal Antibody Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Biosimilar Monoclonal Antibody Total Market Size and Growth Rate from Consumption End

    • 5.5 China Biosimilar Monoclonal Antibody Market Size and Growth Rate, by Application

      • 5.5.1 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Chronic & Autoimmune Diseases

      • 5.5.2 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Oncology

      • 5.5.3 China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others

    Chapter 6 China Biosimilar Monoclonal Antibody Market, by Region

    • 6.1 China Biosimilar Monoclonal Antibody Production Volume and Production Value, by Region

    • 6.2 China Biosimilar Monoclonal Antibody Sales Volume and Sales Value, by Region

    Chapter 7 North China Biosimilar Monoclonal Antibody Market Analysis

    • 7.1 North China Biosimilar Monoclonal Antibody Market, by Type

    • 7.2 North China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 8 Central China Biosimilar Monoclonal Antibody Market Analysis

    • 8.1 Central China Biosimilar Monoclonal Antibody Market, by Type

    • 8.2 Central China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 9 South China Biosimilar Monoclonal Antibody Market Analysis

    • 9.1 South China Biosimilar Monoclonal Antibody Market, by Type

    • 9.2 South China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 10 East China Biosimilar Monoclonal Antibody Market Analysis

    • 10.1 East China Biosimilar Monoclonal Antibody Market, by Type

    • 10.2 East China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 11 Northeast China Biosimilar Monoclonal Antibody Market Analysis

    • 11.1 Northeast China Biosimilar Monoclonal Antibody Market, by Type

    • 11.2 Northeast China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 12 Southwest China Biosimilar Monoclonal Antibody Market Analysis

    • 12.1 Southwest China Biosimilar Monoclonal Antibody Market, by Type

    • 12.2 Southwest China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 13 Northwest China Biosimilar Monoclonal Antibody Market Analysis

    • 13.1 Northwest China Biosimilar Monoclonal Antibody Market, by Type

    • 13.2 Northwest China Biosimilar Monoclonal Antibody Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Intas Pharmaceuticals Limited

        • 14.1.1 Intas Pharmaceuticals Limited Company Profile

        • 14.1.2 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibody Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Genor BioPharma Co Ltd

        • 14.2.1 Genor BioPharma Co Ltd Company Profile

        • 14.2.2 Genor BioPharma Co Ltd Biosimilar Monoclonal Antibody Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Dr Reddys Laboratories Ltd

        • 14.3.1 Dr Reddys Laboratories Ltd Company Profile

        • 14.3.2 Dr Reddys Laboratories Ltd Biosimilar Monoclonal Antibody Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Coherus BioSciences Inc

        • 14.4.1 Coherus BioSciences Inc Company Profile

        • 14.4.2 Coherus BioSciences Inc Biosimilar Monoclonal Antibody Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 BIOCAD BioXpress

        • 14.5.1 BIOCAD BioXpress Company Profile

        • 14.5.2 BIOCAD BioXpress Biosimilar Monoclonal Antibody Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biocon Limited

        • 14.6.1 Biocon Limited Company Profile

        • 14.6.2 Biocon Limited Biosimilar Monoclonal Antibody Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Therapeutics SA

        • 14.7.1 Therapeutics SA Company Profile

        • 14.7.2 Therapeutics SA Biosimilar Monoclonal Antibody Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Boehringer Ingelheim GmbH

        • 14.8.1 Boehringer Ingelheim GmbH Company Profile

        • 14.8.2 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibody Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Celltrion Inc

        • 14.9.1 Celltrion Inc Company Profile

        • 14.9.2 Celltrion Inc Biosimilar Monoclonal Antibody Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Biosimilar Monoclonal Antibody Industry Research Conclusions

    • 15.2 Biosimilar Monoclonal Antibody Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Biosimilar Monoclonal Antibody Industry Market Size (2018-2029)

    • Figure China Biosimilar Monoclonal Antibody Production Volume, Production Value and Growth Rate of Biopharmaceuticals (2018-2029)

    • Figure China Biosimilar Monoclonal Antibody Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Biosimilar Monoclonal Antibody Production Volume, Production Value and Growth Rate of Synthetic Chemicals (2018-2029)

    • Figure China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate of Chronic & Autoimmune Diseases (2018-2029)

    • Figure China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure Central China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure South China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure East China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Biosimilar Monoclonal Antibody Market Size and Growth Rate from 2018-2029

    • Figure Biosimilar Monoclonal Antibody Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Biosimilar Monoclonal Antibody Market Share by Type in 2018

    • Figure China Biosimilar Monoclonal Antibody Market Share by Type in 2023

    • Figure China Biosimilar Monoclonal Antibody Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Production Volume and Growth Rate of Biopharmaceuticals (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Production Volume and Growth Rate of Synthetic Chemicals (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Market Share by Application in 2018

    • Figure China Biosimilar Monoclonal Antibody Market Share by Application in 2023

    • Figure China Biosimilar Monoclonal Antibody Total Market Size and Growth Rate from Consumption End

    • Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Chronic & Autoimmune Diseases (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Production Volume by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Production Volume Share by Region (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Production Volume Share by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Production Value by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Production Value Share by Region (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Production Value Share by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Sales Volume by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Sales Volume Share by Region (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Sales Volume Share by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Sales Value by Region (2018-2023)

    • Table China Biosimilar Monoclonal Antibody Sales Value Share by Region (2018-2023)

    • Figure China Biosimilar Monoclonal Antibody Sales Value Share by Region (2018-2023)

    • Table North China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table North China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure North China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table North China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table North China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure North China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table Central China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table Central China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure Central China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table Central China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table Central China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure Central China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table South China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table South China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure South China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table South China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table South China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure South China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table East China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table East China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure East China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table East China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table East China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure East China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table Northeast China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table Northeast China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure Northeast China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table Northeast China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table Northeast China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table Southwest China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table Southwest China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure Southwest China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table Southwest China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table Southwest China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table Northwest China Biosimilar Monoclonal Antibody Production Volume by Type (2018-2023)

    • Table Northwest China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Figure Northwest China Biosimilar Monoclonal Antibody Production Volume Share by Type (2018-2023)

    • Table Northwest China Biosimilar Monoclonal Antibody Sales Volume by Application (2018-2023)

    • Table Northwest China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Biosimilar Monoclonal Antibody Sales Volume Share by Application (2018-2023)

    • Table Intas Pharmaceuticals Limited Company Profile

    • Table Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Genor BioPharma Co Ltd Company Profile

    • Table Genor BioPharma Co Ltd Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Dr Reddys Laboratories Ltd Company Profile

    • Table Dr Reddys Laboratories Ltd Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Coherus BioSciences Inc Company Profile

    • Table Coherus BioSciences Inc Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table BIOCAD BioXpress Company Profile

    • Table BIOCAD BioXpress Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Biocon Limited Company Profile

    • Table Biocon Limited Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Therapeutics SA Company Profile

    • Table Therapeutics SA Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)

    • Table Celltrion Inc Company Profile

    • Table Celltrion Inc Biosimilar Monoclonal Antibody Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US